Cited 0 times in Scipus Cited Count

237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)

DC Field Value Language
dc.contributor.authorKim, KH-
dc.contributor.authorLee, HJ-
dc.contributor.authorLee, SJ-
dc.contributor.authorKim, M-
dc.contributor.authorAhn, MS-
dc.contributor.authorChoi, MY-
dc.contributor.authorLee, NR-
dc.contributor.authorJung, M-
dc.contributor.authorShin, SJ-
dc.date.accessioned2023-04-20T04:36:05Z-
dc.date.available2023-04-20T04:36:05Z-
dc.date.issued2022-
dc.identifier.issn0959-8049-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25254-
dc.language.isoen-
dc.title237 (PB117) - A phase II study to evaluate the efficacy of regorafenib in C-KIT mutated metastatic malignant melanoma patients who have progressed on first-line treatment: A Multicenter Trial of Korean Cancer Study Group (UN-14–13)-
dc.typeArticle-
dc.contributor.affiliatedAuthorAhn, MS-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/S0959-8049(22)01025-5-
dc.citation.titleEuropean journal of cancer (Oxford, England : 1990)-
dc.citation.volume174-
dc.citation.numberS1-
dc.citation.date2022-
dc.citation.startPageS85-
dc.citation.endPageS86-
dc.identifier.bibliographicCitationEuropean journal of cancer (Oxford, England : 1990), 174(S1). : S85-S86, 2022-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1879-0852-
dc.relation.journalidJ009598049-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse